Presented by Dr. Arden Morris, MD
Professor of Surgery (General Surgery)
Stanford University Medical Center
Arden M. Morris, MD, MPH is professor and vice chair of clinical research in the Department of Surgery, director of the Stanford-Surgery Policy, Improvement Research and Education (S-SPIRE) Center, and core faculty in the Stanford Department of Health Research and Policy. Dr. Morris joined Stanford in 2016 from the University of Michigan where she was an associate professor and division chief of colorectal surgery. In her research, she uses mixed methods to focus on improving quality and equity in surgical care. She has deployed her expertise in a number of leadership and advisory roles and policy panels such as National Quality Forum’s Consensus Standards and Approval Committee and the Medicare Coverage Advisory Committee.
INFORMATION SERVICES LIBRARIAN, SCHOOL OF MEDICINE – LANE MEDICAL LIBRARY
Amber Trickey, PhD
Stanford-Surgery Policy Improvement Research and Education Center
Health Services Research Unit
Amber Trickey, PhD, MS, CPH is Senior Biostatistician of the S-SPIRE Center. She supports multidisciplinary teams in research design, implementation, and analysis. In 15 years of health services research, with 8 years focused in surgery, Dr. Trickey has collaborated with diverse investigators, including attending physicians, residents, nurses, psychologists, and engineers. Dr. Trickey obtained degrees in epidemiology and biostatistics, evaluated data quality in trauma care, and led data validation studies using a surgical registry (NSQIP) and administrative claims. Dr. Trickey has contributed to public and private grants on surgical safety, simulation-based training, team communication, error disclosure, and quality metrics.
Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer. The date of the event is Friday September 30, 2022 at 4pm. It will be a hybrid event.
Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.
Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.
Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.
Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.
Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.